Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Atorvastatin Sodium (Lipitor) is a competitive inhibitor of HMG-CoA reductase and increases the expression of low density lipoprotein (LDL) receptors on hepatocytes. Atorvastatin Sodium treatment inhibits aquaporin 4 to reduce ischaemic brain oedema.
パッケージサイズ | 在庫状況 | 単価(税別) | |||
---|---|---|---|---|---|
サンプルについてお問い合わせ | |||||
10 mg | 在庫あり | ¥ 11,500 | |||
25 mg | 在庫あり | ¥ 20,000 | |||
50 mg | 在庫あり | ¥ 30,000 | |||
100 mg | 在庫あり | ¥ 44,500 | |||
1 mL * 10 mM (in DMSO) | 在庫あり | ¥ 15,000 |
説明 | Atorvastatin Sodium (Lipitor) is a competitive inhibitor of HMG-CoA reductase and increases the expression of low density lipoprotein (LDL) receptors on hepatocytes. Atorvastatin Sodium treatment inhibits aquaporin 4 to reduce ischaemic brain oedema. |
別名 | Lipitor |
分子量 | 581.63 |
分子式 | C33H35FN2NaO5 |
CAS No. | 134523-01-6 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 5.81 mg/mL (10 mM), Sonication is recommended.
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Atorvastatin Sodium 134523-01-6 Membrane transporter/Ion channel Metabolism Aquaporin LDL HMG-CoA Reductase Lipitor Inhibitor inhibitor inhibit